NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. (“Summit” or the “Company”) (NASDAQ: SMMT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Summit and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. – SMMT
Category: Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lloyds Banking Group plc – LYG
NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Lloyds Banking Group plc (“Lloyds” or the “Company”) (NYSE: LYG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Lloyds and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lloyds Banking Group plc – LYG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Thoughtworks Holding, Inc. – TWKS
NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Thoughtworks Holding, Inc. (“Thoughtworks” or the “Company”) (NASDAQ: TWKS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Thoughtworks and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Thoughtworks Holding, Inc. – TWKS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. – BIIB
NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Biogen and certain of its officers and/or directors have engaged in securities fraud or other unlawful… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. – BIIB
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Evolv Technologies Holdings, Inc. – EVLV
NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”) (NASDAQ: EVLV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Evolv and certain of its officers and/or directors have engaged in securities fraud or other unlawful… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Evolv Technologies Holdings, Inc. – EVLV
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of The Chemours Company – CC
NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Chemours and certain of its officers and/or directors have engaged in securities… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of The Chemours Company – CC
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. – RAPT
NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of RAPT Therapeutics, Inc. (“RAPT” or the “Company”) (NASDAQ: RAPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether RAPT and certain of its officers and/or directors have engaged in securities… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. – RAPT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. – ALNY
NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc. (“Alnylam” or the “Company”) (NASDAQ: ALNY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Alnylam and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. – ALNY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Temenos AG – TMSNY
NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Temenos AG (“Temenos” or the “Company”) (OTC: TMSNY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Temenos and certain of its officers and/or directors have engaged in securities fraud… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Temenos AG – TMSNY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of QuidelOrtho Corporation – QDEL
NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether QuidelOrtho and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. … Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of QuidelOrtho Corporation – QDEL